Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05054257
What this trial is testing

CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma RefractoryNon-Hodgkin's Lymphoma, Relapsed
Institute of Hematology and Blood Transfusion, Czech Republic 10
Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00072514
What this trial is testing

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT02939014
What this trial is testing

Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)

Who this might be right for
Hodgkin DiseaseLymphoma, Large-Cell, Anaplastic
Takeda 39
Large-scale testing (Phase 3)UnknownNCT03023358
What this trial is testing

Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients

Who this might be right for
Peripheral T Cell Lymphoma
Nanfang Hospital, Southern Medical University 174
Testing effectiveness (Phase 2)UnknownNCT01991158
What this trial is testing

GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06564038
What this trial is testing

AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukaemiaSmall Lymphocytic LymphomaMantle-cell Lymphoma+2 more
AstraZeneca 408
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07032532
What this trial is testing

Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)

Who this might be right for
Peripheral T Cell Lymphoma
Sun Yat-sen University 35
Testing effectiveness (Phase 2)UnknownNCT05749549
What this trial is testing

Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers

Who this might be right for
Advanced CancerFollicular LymphomaPeripheral T Cell Lymphoma+1 more
Shanghai Blueray Biopharma Co., Ltd. 191
Early research (Phase 1)Study completedNCT04067414
What this trial is testing

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma+1 more
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Study completedNCT00901147
What this trial is testing

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma (Not Otherwise Specified)Angioimmunoblastic T-cell LymphomaExtranodal NK/T-cell Lymphoma Nasal Type+4 more
Singapore General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT02273739
What this trial is testing

Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

Who this might be right for
Solid TumorGliomaAngioimmunoblastic T-cell Lymphoma+2 more
Celgene 21
Early research (Phase 1)Study completedNCT02924402
What this trial is testing

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

Who this might be right for
B-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Xencor, Inc. 154
Early research (Phase 1)Ended earlyNCT06254495
What this trial is testing

A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers

Who this might be right for
Hodgkin DiseaseLymphoma, T-Cell, PeripheralLymphoma, Large B-Cell, Diffuse+1 more
Seagen, a wholly owned subsidiary of Pfizer 58
Not applicableLooking for participantsNCT03375619
What this trial is testing

Long-term Follow-up Study of Patients Receiving CAR-T Cells

Who this might be right for
Chronic Lymphocytic LeukemiaLymphomas Non-Hodgkin's B-CellLymphoma, Small Lymphocytic+6 more
Medical College of Wisconsin 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT06953739
What this trial is testing

A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.

Who this might be right for
NK-T-Cell Lymphoma, Extranodal
The First Affiliated Hospital with Nanjing Medical University 60
Testing effectiveness (Phase 2)UnknownNCT03502629
What this trial is testing

Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)

Who this might be right for
Peripheral T Cell Lymphoma
Genor Biopharma Co., Ltd. 86
Very early researchLooking for participantsNCT07048353
What this trial is testing

CD30 CAR-T in the Treatment of CD30 Positive Lymphoma

Who this might be right for
LymphomaB Cell LymphomaCD30+ Peripheral T-cell Lymphoma
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd 15
Testing effectiveness (Phase 2)Ended earlyNCT00112723
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06573151
What this trial is testing

Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL

Who this might be right for
Lymphoma
Ruijin Hospital 28
Next Page